General Information


DRAVP ID  DRAVPe00550

Peptide Name   C16- N25

Sequence  RQLLSGIVQQQNNLLRAIEAQQHLL

Sequence Length  25

UniProt ID  No entry found

Taxon ID  None

Source  Synthetic construct

Validation   Experimentally Validated



Origin Information


Gene Name/ID  Not Available

GenBank  Not Available

Amino Acid position  Not Available

Domain Accession ID  Not Available

Nucleotide sequence ID  Not Available

Molecular Type  Not Available

Chromosomal Position  Not Available



Activity Information


Target Organism  HIV

Assay  cell-cell fusion inhibition assay

Activity 

  • [Ref.20605950]HIV-1:inhibition of peptide against cell-cell fusion between Jurkat E6-1 and HXBc2 cells(IC50=484±60 nM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  membrane

Mechanism  N peptide may target an exposed C-helix region of gp41 and can interact with their coiled coil formation within a gp41 dimer,which can inhibit HIV-1 entry.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00550

Linear/Cyclic  Linear

N-terminal Modification  C16(hexadecanoic acid)

C-terminal Modification  Free

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C125H215N41O37

Absent amino acids  CDFKMPTWY

Common amino acids  LQ

Mass  2884.33

Pl  9.61

Basic residues  3

Acidic residues  1

Hydrophobic residues  11

Net charge  2

Boman Index  -4327

Hydrophobicity  -21.2

Aliphatic Index  144.4

Half Life 

  •     Mammalian:1 hour
  •     Yeast:2 min
  •     E.coli:2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4



Literature Information


Literature 1

Title   Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain. 

Pubmed ID   20605950

Reference   FASEB J. 2010 Nov;24(11):4196-202. 

Author   Wexler-Cohen Y, Ashkenazi A, Viard M, Blumenthal R, Shai Y.

DOI   10.1096/fj.09-151704